Oliver Körner
Oliver Körner has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Alan Jones
BASF , Research Triangle Park, NC
1 shared publication Carola Schriever
BASF Agricultural Solutions Deutschland GmbH
1 shared publication- Grace H. Panter
Wca environment Ltd , Faringdon
1 shared publication - Laurent Lagadic
Bayer AG, Crop Science Division, Environmental Safety, Ecotoxicology, Monheim am Rhein, Germany
1 shared publication - Lennart Weltje
Agricultural Solutions—Ecotoxicology, BASF SE , Limburgerhof
1 shared publication - Rebecca J. Brown
Wca environment Ltd , Faringdon
1 shared publication
Latest Publications
- Open Access
- 14 October 2026
- Published by Taylor & Francis in Journal of Freshwater Ecology
- Vol. 41 (1)
Relevance of pesticides for macroinvertebrate communities in agricultural streams – a re-evaluation
1. Agricultural streams worldwide are exposed to multiple interacting stressors, including pesticide contamination, nutrient enrichment, altered hydrology, habitat degradation, oxygen depletion, an...
- 14 October 2026
- Published by Taylor & Francis in Journal of Freshwater Ecology
- Vol. 41 (1)
Open AccessRelevance of pesticides for macroinvertebrate communities in agricultural streams – a re-evaluation
1. Agricultural streams worldwide are exposed to multiple interacting stressors, including pesticide contamination, nutrient enrichment, altered hydrology, habitat degradation, oxygen depletion, an...
- Open Access
- 28 May 2023
- Published by Taylor & Francis in Critical Reviews in Toxicology
- Vol. 53 (5) , 326-338
Detection of anti-androgenic activity of chemicals in fish studies: a data review
A systematic review was conducted on the sensitivity of fish testing guidelines to detect the anti-androgenic activity of substances. Sequence Alignment to Predict Across Species Susceptibility (SeqAPASS) was used to investigate the conservation of the androgen receptor (AR) between humans and fish, and among fish species recommended in test guidelines. The AR is conserved between fish species and humans (i.e. ligand binding domain [LBD] homology ≥70%) and among the recommended fish species (LBD homology >85%). For model anti-androgens, we evaluated literature data on in vitro anti-androgenic activity in fish-specific receptor-based assays and changes in endpoints indicative of endocrine modulation from in vivo studies. Anti-androgenic activity was most consistently and reliably detected in in vitro and in vivo mechanistic studies with co-exposure to an androgen (spiggin in vitro assay, Rapid Androgen Disruption Activity Reporter [RADAR] Assay, and Androgenised Female Stickleback Screen). Regardless of study design (Fish Short-Term Reproduction Assay [FSTRA], Fish Sexual Development Test [FSDT], partial or full life-cycle tests), or endpoint (vitellogenin, secondary sexual characteristics, gonadal histopathology, sex ratio), there was no consistent evidence for detecting anti-androgenic activity in studies without androgen co-exposure, even for the most potent substances (while less potent substances may induce no (clear) response). Therefore, based on studies without androgen co-exposure (35 FSTRAs and 22 other studies), the other studies (including the FSDT) do not outperform the FSTRA for detecting potent anti-androgenic activity, which if suspected, would be best addressed with a RADAR assay. Overall, fish do not appear particularly sensitive to mammalian anti-androgens.
- 28 May 2023
- Published by Taylor & Francis in Critical Reviews in Toxicology
- Vol. 53 (5) , 326-338
Open AccessDetection of anti-androgenic activity of chemicals in fish studies: a data review
A systematic review was conducted on the sensitivity of fish testing guidelines to detect the anti-androgenic activity of substances. Sequence Alignment to Predict Across Species Susceptibility (SeqAPASS) was used to investigate the conservation of the androgen receptor (AR) between humans and fish, and among fish species recommended in test guidelines. The AR is conserved between fish species and humans (i.e. ligand binding domain [LBD] homology ≥70%) and among the recommended fish species (LBD homology >85%). For model anti-androgens, we evaluated literature data on in vitro anti-androgenic activity in fish-specific receptor-based assays and changes in endpoints indicative of endocrine modulation from in vivo studies. Anti-androgenic activity was most consistently and reliably detected in in vitro and in vivo mechanistic studies with co-exposure to an androgen (spiggin in vitro assay, Rapid Androgen Disruption Activity Reporter [RADAR] Assay, and Androgenised Female Stickleback Screen). Regardless of study design (Fish Short-Term Reproduction Assay [FSTRA], Fish Sexual Development Test [FSDT], partial or full life-cycle tests), or endpoint (vitellogenin, secondary sexual characteristics, gonadal histopathology, sex ratio), there was no consistent evidence for detecting anti-androgenic activity in studies without androgen co-exposure, even for the most potent substances (while less potent substances may induce no (clear) response). Therefore, based on studies without androgen co-exposure (35 FSTRAs and 22 other studies), the other studies (including the FSDT) do not outperform the FSTRA for detecting potent anti-androgenic activity, which if suspected, would be best addressed with a RADAR assay. Overall, fish do not appear particularly sensitive to mammalian anti-androgens.